Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Anemia, Refractory, with Excess of Blasts × Watchful Waiting × 90 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 7 Carcinoma, Non-Small-Cell Lung 4 Colonic Neoplasms 3 Uterine Cervical Neoplasms 2 Uterine Cervical Dysplasia 2 Triple Negative Breast Neoplasms 2 Oropharyngeal Neoplasms 2 Lung Neoplasms 2 Carcinoma, Renal Cell 2 Breast Neoplasms 2 Uveal Melanoma 1 Uterine Neoplasms 1 Uterine Diseases 1 Uterine Cervical Diseases 1 Urogenital Neoplasms 1 Urogenital Diseases 1 Ureteral Neoplasms 1 Thyroid Nodule 1 Thyroid Neoplasms 1 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Retinoblastoma 1 Rectal Neoplasms 1 Precancerous Conditions 1 Pleuropulmonary blastoma 1 Pelvic Neoplasms 1 Papillomavirus Infections 1 Neuroblastoma 1 Neoplasms by Site 1 Neoplasms 1 Neoplasm Metastasis 1

Interventions

Cyclophosphamide 6 fludarabine 5 Mycophenolic Acid 5 Azacitidine 5 Whole-Body Irradiation 4 Tacrolimus 4 venetoclax 3 fludarabine phosphate 3 decitabine and cedazuridine drug combination 2 Vorinostat 2 Specimen Handling 2 Melphalan 2 Granulocyte Colony-Stimulating Factor 2 Busulfan 2 Biopsy 2 sulforaphane 1 ruxolitinib 1 enasidenib 1 cedazuridine 1 Triamcinolone 1 TAK-243 1 Stem Cell Transplantation 1 Sirolimus 1 Peripheral Blood Stem Cell Transplantation 1 Mesna 1 Lenalidomide 1 Hematopoietic Stem Cell Transplantation 1 Filgrastim 1 Cyclosporins 1 Cyclosporine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡